基础医学与临床 ›› 2010, Vol. 30 ›› Issue (12): 1325-1328.

• 研究论文 • 上一篇    下一篇

前列腺癌空间分布特点的临床分析

严维刚1,李汉忠1,周毅1,崔全才2   

  1. 1. 中国医学科学院北京协和医学院北京协和医院泌尿外科2. 中国医学科学院 北京协和医学院 北京协和医院 病理科
  • 收稿日期:2010-01-22 修回日期:2010-05-24 出版日期:2010-12-05 发布日期:2010-12-05
  • 通讯作者: 李汉忠

Clinical evaluation of prostate cancer spatial distribution

YAN Wei-gang 1,LI Han-zhong 1,ZHOU Yi 1,CUI Quan-cai 2   

  1. 1. Department of Urology, Peking Union Medical College Hospital, CAMS & PUMC2. Department of Pathology, PUMC Hospital, CAMS & PUMC
  • Received:2010-01-22 Revised:2010-05-24 Online:2010-12-05 Published:2010-12-05
  • Contact: LI Han-zhong

摘要: 目的 通过定位模板经直肠超声引导下经会阴11区穿刺活检,探讨前列腺癌在前列腺组织中的空间分布特点。 方法 2004年5月~2007年12月,215例前列腺癌患者通过11区经会阴前列腺穿刺活检证实,年龄37~87岁(平均71.8岁),PSA1.2~100ng/mL(中位数21.0 ng/mL),分析其在不同前列腺特异性抗原(PSA)水平前列腺癌病灶在11个区域及前后分布特点。结果 110例PSA>20ng/mL前列腺癌患者第1~10区平均检出率为61.2%和第11区的66.4%,无差异。105例PSA ≤20ng/mL患者第1~10区检出率平均值为35.7%,显著低于第11区的47.6%(P<0.001)。PSA>20ng/mL者前列腺前半部分和后半部分的检出率分别为96.5%和90.9%, PSA≤20ng/mL者检出率均为75.2%,无差异。结论 前列腺癌病灶在前后分布上无显著性区别。在PSA<20ng/mL前列腺癌患者,尖部发生率显著高于其他部位。

关键词: 前列腺癌分布, 活检, 前列腺特异性抗原

Abstract: Objective We analyzed the prostate biopsy data obtained with a transperineal ultrasound and thereafter navigated the 11-region prostate biopsy template in a sample population to evaluate prostate cancer spatial distribution characteristics. Methods From May 2004 to December 2007, 215 patients with a median prostate-specific antigen (PSA) level of 21.0 ng/ml (range 1.2 to 100) were diagnosed with prostate cancer through the transperineal ultrasound guided 11-region template prostate biopsy at Peking Union Medical College Hospital. The characteristics of our sample cancer spatial distribution were assessed in relation with different PSA levels. Results The mean positives for the cancer of regions 1-10 and region 11 (the apical region) were 61.2% vs. 66.4% in patients whose PSA > 20ng/ml , and 35.7% vs. 47.6% in patients with PSA ≤ 20ng/ml (P<0.001). The positives for cancer contained within the anterior and posterior areas were 96.5% vs. 90.9% in patients with PSA > 20ng/ml and 75.2% vs. 75.2% in patients with PSA ≤ 20ng/ml. Conclusions Our findings suggest that there is no difference in cancer distribution between anterior and posterior parts of prostate. Prostate cancers in PSA level less than 20ng/ml patients are more frequently found in the apical region, but no different rate is found in these regions in higher PSA level patients.